SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000906344-08-000740
Filing Date
2008-10-06
Accepted
2008-10-06 14:48:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (10-6-08) celltherapeutics-13g.htm SC 13G 112415
  Complete submission text file 0000906344-08-000740.txt   114276
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 081109206
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FERRY BUILDING SUITE 255 SAN FRANCISCO CA 94111
Business Address 1 FERRY BUILDING SUITE 255 SAN FRANCISCO CA 94111 415-677-1577
Enable Growth Partners L P (Filed by) CIK: 0001316907 (see all company filings)

IRS No.: 000000000
Type: SC 13G